Aileron Therapeutics, Inc. Recorded Big Gain
Fri 10 Jan 20 at 05:30 PM
Aileron Therapeutics, Inc. (ALRN:NASDAQ) rocketted at $0.82, a gain of 25%. On Thu 09 Jan 20, ALRN:NASDAQ touched a New 2-Week High of $0.66. The stock appeared on our News Catalysts scanner on Thu 19 Dec 19 at 07:57 AM in the 'INSIDER' category. From Wed 18 Dec 19, the stock recorded 64.29% Up Days and 46.67% Green Days
The share price of the company has been moving sideways in recent weeks.
About Aileron Therapeutics, Inc. (ALRN:NASDAQ)
Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company that is focused on developing and commercializing a novel class of therapeutics called stapled peptides.
Top 10 Gainers:
- CounterPath Corporation (CPAH:NASDAQ), 304.12%
- Origin Agritech Limited (SEED:NASDAQ), 46.92%
- China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ), 42.67%
- Sorrento Therapeutics, Inc. (SRNE:NASDAQ), 39.59%
- Proteon Therapeutics, Inc. (PRTO:NASDAQ), 30.5%
- Lianluo Smart Limited (LLIT:NASDAQ), 28.57%
- Co-Diagnostics, Inc. (CODX:NASDAQ), 28.54%
- Akari Therapeutics, Plc (AKTX:NASDAQ), 25.43%
- Aileron Therapeutics, Inc. (ALRN:NASDAQ), 24.97%
- Nektar Therapeutics (NKTR:NASDAQ), 24.69%